EMA: New Medicines Development Tools

The European Medicines Agency (EMA) has launched new features for PRIME, its scheme to enhance support for developing medicines targeting unmet medical needs. These tools aim to accelerate the process of bringing innovative treatments to patients in the EU. The launch supports quicker assessments and pathways to market. The additions should reduce development bottlenecks.

Read source